 Connection
Benedetto Mungo to Pancreatic Neoplasms
This is a "connection" page, showing publications Benedetto Mungo has written about Pancreatic Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.052 |
|
|
|
-
Mungo B, Hammad A, AlMasri S, Dogeas E, Nassour I, Singhi AD, Zeh HJ, Hogg ME, Lee KKW, Zureikat AH, Paniccia A. Pancreaticoduodenectomy for benign and premalignant pancreatic and ampullary disease: is robotic surgery the better approach? Surg Endosc. 2023 02; 37(2):1157-1165.
Score: 0.445
-
Mungo B, Croce C, Oba A, Ahrendt S, Gleisner A, Friedman C, Schulick RD, Del Chiaro M. Controversial Role of Adjuvant Therapy in Node-Negative Invasive Intraductal Papillary Mucinous Neoplasm. Ann Surg Oncol. 2021 Mar; 28(3):1533-1542.
Score: 0.384
-
Yee EJ, Torphy RJ, Myers EK, Meguid C, Franklin O, Sugawara T, Franco SR, Clark TJ, Mungo B, Ahrendt SA, Schulick RD, Del Chiaro M, McCarter MM. Dynamic Anthropometrics in Pancreatic Cancer: Associations Between Body Composition Changes During Neoadjuvant Therapy and Survival Outcomes After Resection. Ann Surg Oncol. 2024 Nov; 31(12):8340-8351.
Score: 0.127
-
Croce C, Mungo B, Oba A, Schulick RD, Del Chiaro M. ASO Author Reflections: Which Patients with Invasive Intraductal Papillary Mucinous Neoplasm Can Benefit from Adjuvant Therapy? Ann Surg Oncol. 2020 Dec; 27(Suppl 3):873-874.
Score: 0.097
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|